Platelet Rich Plasma for Knee Osteoarthritis
Intraoperative Platelet Rich Plasma Injection in Arthroscopic Surgery for Osteoarthritis of the Knee
1 other identifier
interventional
12
1 country
1
Brief Summary
This study aimed to analyze the effect of platelet-rich plasma (PRP) on knee osteoarthritis. Eligible patients will undertake arthroscopic knee surgery plus intraoperative PRP and also receive second look surgery and intraoperative biopsy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 29, 2016
CompletedFirst Submitted
Initial submission to the registry
April 13, 2017
CompletedFirst Posted
Study publicly available on registry
June 23, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 28, 2018
CompletedSeptember 6, 2019
September 1, 2019
1.8 years
April 13, 2017
September 5, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in knee function from baseline to postoperative 3 months
Knee function is evaluated using Oswestry Disability Index preoperatively and 3-month postoperatively.
3-month postoperative
Secondary Outcomes (7)
Change in knee function from baseline to postoperative 6 months
6-month postoperative
Change in knee function from baseline to postoperative 12 months
12-month postoperative
Change in knee pain from baseline to postoperative 3 months
3-month postoperative
Change in knee pain from baseline to postoperative 6 months
6-month postoperative
Change in knee pain from baseline to postoperative 12 months
12-month postoperative
- +2 more secondary outcomes
Study Arms (1)
PRP group
EXPERIMENTALArthroscopic knee surgery plus intraoperative platelet-rich plasma
Interventions
Intraoperative platelet-rich plasma injection during arthroscopic knee surgery
Eligibility Criteria
You may qualify if:
- Age between 30 and 70 years
- With diagnosis of osteoarthritis, grade II\~grade IV, II-III medial compartment
You may not qualify if:
- Lateral compartment and patellofemoral joint osteoarthritis
- With prior history of knee surgery
- Severe varus deformity
- With current or prior history of traum or infection at the knee
- With current or prior history of cancer
- With current or prior history of hematological disease
- Pregnancy
- Patients who will not cooperate with one-year followup
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pei-Yuan Lee, MDlead
- Aeon Biotechnology Corporationcollaborator
Study Sites (1)
Show Chwan Memorial Hospital
Changhua, Changhua, 500, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Pei-Yuan Lee, MD
Show Chwan Memorial Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Superintendent
Study Record Dates
First Submitted
April 13, 2017
First Posted
June 23, 2017
Study Start
August 29, 2016
Primary Completion
June 28, 2018
Study Completion
June 28, 2018
Last Updated
September 6, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share